10 Health Care Stocks Whale Activity In Today’s Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums…
Deep Dive Into United Therapeutics Stock: Analyst Perspectives (5 Ratings)
United Therapeutics (NASDAQ:UTHR) underwent analysis by 5 analysts in the last quarter, revealing a spectrum of viewpoints from…
10 Health Care Stocks With Whale Alerts In Today’s Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums…
Expert Ratings For United Therapeutics
During the last three months, 7 analysts shared their evaluations of United Therapeutics (NASDAQ:UTHR), revealing diverse outlooks from…
The Latest Analyst Ratings For United Therapeutics
Throughout the last three months, 7 analysts have evaluated United Therapeutics (NASDAQ:UTHR), offering a diverse set of opinions…
Lung Disease-Focused United Therapeutics Says It Is A Compelling Investment Opportunity
United Therapeutics impresses with record-breaking Q1 results. Revenue soars 34% Y/Y to $677.7 million, EPS jumps to $6.17. Tyvaso leads the charge with a 56% revenue surge.
Powell Industries Posts Upbeat Results, Joins A10 Networks, Garmin, DuPont And Other Big Stocks Moving Higher On Wednesday
U.S. stocks were mixed, with the Dow Jones index gaining over 50 points on Wednesday. Shares of Powell…
12 Health Care Stocks Moving In Tuesday’s After-Market Session
Gainers Apollomics (NASDAQ:APLM) stock rose 10.9% to $0.61 during Tuesday’s after-market session. The market value of their outstanding…
Earnings Outlook For United Therapeutics
United Therapeutics (NASDAQ:UTHR) is set to give its latest quarterly earnings report on Wednesday, 2024-02-21. Here’s what investors…
This United Therapeutics Analyst Is No Longer Bearish, Expects Mid-Decade $4B Revenue Run Rate
United Therapeutics Corporation (NASDAQ: UTHR) is in a patent dispute with Liquidia Corp (NASDAQ: